Back to search
Central Nervous System Nongerminomatous Germ Cell Tumor
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Central Nervous System Nongerminomatous Germ Cell Tumor trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Central Nervous System Nongerminomatous Germ Cell Tumor trials you may qualify forThe purpose of this study is to evaluate feasibility and acceptability of completing PROs among AYAs randomized to Choice PRO vs Fixed PRO.
This phase II trial studies the best approach to combine chemotherapy and radiation therapy (RT) based on the patient's response to induction chemotherapy in pa…
This phase II trial studies how well chemotherapy followed by radiation therapy work in treating younger patients with newly diagnosed central nervous system ge…
RATIONALE: Giving high-dose chemotherapy before an autologous stem cell transplant stops the growth of tumor cells by stopping them from dividing or killing the…